| Ethical and philosophical consideration of the dual-use dilemma in the biological sciences S Miller, MJ Selgelid Science and engineering ethics 13, 523-580, 2007 | 296 | 2007 |
| ETHICS AND INFECTIOUS DISEASE1 MJ Selgelid Bioethics 19 (3), 272-289, 2005 | 230 | 2005 |
| COVID-19 human challenge studies: ethical issues E Jamrozik, MJ Selgelid The Lancet Infectious Diseases 20 (8), e198-e203, 2020 | 161 | 2020 |
| Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine A Wilder-Smith, J Hombach, N Ferguson, M Selgelid, K O'Brien, ... The Lancet infectious diseases 19 (1), e31-e38, 2019 | 149 | 2019 |
| Ethics of controlled human infection to address COVID-19 SK Shah, FG Miller, TC Darton, D Duenas, C Emerson, HF Lynch, ... Science 368 (6493), 832-834, 2020 | 134 | 2020 |
| Ethical criteria for human challenge studies in infectious diseases B Bambery, M Selgelid, C Weijer, J Savulescu, AJ Pollard Public health ethics 9 (1), 92-103, 2016 | 131 | 2016 |
| Governance of dual-use research: an ethical dilemma MJ Selgelid Bulletin of the World Health Organization 87, 720-723, 2009 | 110 | 2009 |
| Pandethics MJ Selgelid Public health 123 (3), 255-259, 2009 | 106 | 2009 |
| Gain-of-function research: ethical analysis MJ Selgelid Science and Engineering Ethics 22, 923-964, 2016 | 97 | 2016 |
| Ethics and drug resistance MJ Selgelid Bioethics 21 (4), 218-229, 2007 | 84 | 2007 |
| Ethics, tuberculosis and globalization MJ Selgelid Public Health Ethics 1 (1), 10-20, 2008 | 80 | 2008 |
| Placebo use in vaccine trials: recommendations of a WHO expert panel A Rid, A Saxena, AH Baqui, A Bhan, J Bines, MC Bouesseau, A Caplan, ... Vaccine 32 (37), 4708-4712, 2014 | 74 | 2014 |
| Ethical considerations for vaccination programmes in acute humanitarian emergencies K Moodley, K Hardie, MJ Selgelid, RJ Waldman, P Strebel, H Rees, ... Bulletin of the World Health Organization 91, 290-297, 2013 | 73 | 2013 |
| Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group E Jamrozik, K Littler, S Bull, C Emerson, G Kang, M Kapulu, E Rey, ... Vaccine 39 (4), 633-640, 2021 | 60 | 2021 |
| Moderate eugenics and human enhancement MJ Selgelid Medicine, Health Care and Philosophy 17, 3-12, 2014 | 60 | 2014 |
| A moderate pluralist approach to public health policy and ethics MJ Selgelid Public Health Ethics 2 (2), 195-205, 2009 | 57 | 2009 |
| Human challenge studies in endemic settings: ethical and regulatory issues E Jamrozik, MJ Selgelid Springer Nature, 2021 | 54 | 2021 |
| Dual-use research codes of conduct: Lessons from the life sciences MJ Selgelid Nanoethics 3, 175-183, 2009 | 53 | 2009 |
| Influenza vaccination strategies should target children B Bambery, T Douglas, MJ Selgelid, H Maslen, A Giubilini, AJ Pollard, ... Public Health Ethics 11 (2), 221-234, 2018 | 52 | 2018 |
| Ethics and drug resistance: collective responsibility for global public health E Jamrozik, M Selgelid Springer Nature, 2020 | 51 | 2020 |
